Background & Aims We evaluated global and regional burdens of, risk factors for, and
epidemiologic trends in pancreatic cancer among groups of different sexes and ages …

Cancer is a complex group of diseases that constitute the second largest cause of mortality
worldwide. The development of new drugs for treating this disease is a long and costly …

Simple Summary Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal
cancers worldwide, with a poor prognosis and an increasing incidence. Recently, the tumor …

Objective Prior studies identified clinical factors associated with increased risk of pancreatic
ductal adenocarcinoma (PDAC). However, little is known regarding their time-varying …

Understanding the functional consequences of genetic variation in the non-coding regions
of the human genome remains a challenge. We introduce h ere a computational tool, TURF …

Pancreatic ductal adenocarcinoma (PDAC) remains an unmet clinical problem in urgent
need of newer molecularly driven treatment modalities. Calcium signals, particularly those …

Cardiovascular disease remains the primary cause of mortality globally, being responsible
for an estimated 17 million deaths every year. Cancer is the second leading cause of death …

Pancreatic cancer is among the most lethal malignancies with poor prognosis and patients
become chemoresistant to current therapies, supporting further investigations to identify new …

Hypertension is the most prevalent comorbidity in cancer patients. Consequently, many
cancer patients are prescribed antihypertensive drugs before cancer diagnosis or during …

Recently updated clinical guidelines have highlighted the gaps in our understanding and
management of pediatric hypertension. With increased recognition and diagnosis of …